Dr. Marzieh Ebrahimi, CEO of Kian Immune Cell, delivered an insightful talk titled “Targeting Cancer Stem Cells by Natural Killer Cells: Lessons from Clinical Trials” at the 22nd International Royan Congress on Stem Cell Biology and Technology, held on September 2–3, 2026, in Tehran, Iran.
The congress brought together leading researchers and experts in stem cell biology and regenerative medicine from across the country and beyond.
In her presentation, Dr. Ebrahimi shared valuable insights drawn from clinical trial experience on how Natural Killer (NK) cells can be leveraged to target and combat cancer stem cells — a critical frontier in the ongoing fight against cancer relapse and treatment resistance.
We are proud to see our CEO continue to contribute to advancing scientific knowledge and sharing groundbreaking research with the global scientific community.
